Zhang Niushen, Tran Stephanie, Moskatel Leon S
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, 211 Quarry Road, Suite 206, Palo Alto, CA, 94304, USA.
Curr Neurol Neurosci Rep. 2025 Feb 22;25(1):20. doi: 10.1007/s11910-025-01408-8.
We provide an overview of the field of microbiome research, the current understanding of the microbiome-gut-brain axis, and the most recent updates on the interplay between migraine and the gut microbiome.
Pre-clinical studies suggest that gut microbiota is required for normal pain sensation. There is also evidence in rodent models that there is potential application of food, herbal medicines, probiotics, and short chain fatty acids (SCFAs) as novel therapies for migraine. Evidence from human cohorts suggests that there is altered gut microbiota in people with migraine, and that the microbiome dysbiosis is from both compositional and functional aspects. Recent metagenome-wide association studies (MWAS) that employ Mendelian Randomization support the causal association between gut microbiota and migraine. The connection between migraine and the gut microbiome remains underexplored, but recent preclinical and clinical studies support the association between gut microbiota and the development of migraine.
我们概述了微生物组研究领域、目前对微生物组-肠-脑轴的理解,以及偏头痛与肠道微生物组之间相互作用的最新进展。
临床前研究表明,正常的痛觉需要肠道微生物群。在啮齿动物模型中也有证据表明,食物、草药、益生菌和短链脂肪酸(SCFAs)作为偏头痛的新疗法具有潜在应用价值。来自人类队列的证据表明,偏头痛患者的肠道微生物群发生了改变,并且微生物组失调在组成和功能方面均存在。最近采用孟德尔随机化的全基因组关联研究(MWAS)支持肠道微生物群与偏头痛之间的因果关联。偏头痛与肠道微生物组之间的联系仍未得到充分探索,但最近的临床前和临床研究支持肠道微生物群与偏头痛发展之间的关联。